Omexa Biologics

Omexa Biologics is an innovative biotechnology company based in Ahmedabad, India, specializing in the development and manufacturing of high-quality biosimilars and complex biologics. Founded by Dr. Sanjay Singh, the former CEO of Gennova Biopharmaceuticals, the company aims to enhance global access to affordable biotherapeutics. Omexa focuses on therapeutic areas with high unmet needs, particularly oncology and immunology, by leveraging advanced bioprocessing and mammalian expression platforms. Their pipeline includes biosimilar versions of widely used monoclonal antibodies, designed to meet stringent international regulatory standards. The company operates state-of-the-art R&D and manufacturing facilities to support the full lifecycle of biologic drug development. By combining technical expertise with a mission for health equity, Omexa Biologics is positioned as a key player in the evolving global biosimilar market.